CTSS and early-onset autosomal dominant Alzheimer disease: In addition, the STAT3/CTSS signaling axis is implicated in diseases such as Alzheimer’s disease, diabetic nephropathy, and vascular calcification, highlighting its therapeutic potential in cardiovascular and neurological disorders (57–59).